BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19728024)

  • 1. Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.
    Sever M; Kantarjian H; Pierce S; Jain N; Estrov Z; Cortes J; Verstovsek S
    Int J Hematol; 2009 Nov; 90(4):522-525. PubMed ID: 19728024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.
    Suleiman Y; Dalia S; Liu JJ; Bowers JW; Padron E; Lancet JE; Fulp W; Moscinski LC; Komrokji RS; Zuckerman KS; Zhang L
    Leuk Res; 2016 Mar; 42():52-8. PubMed ID: 26894965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.
    Gangat N; Tefferi A; Thanarajasingam G; Patnaik M; Schwager S; Ketterling R; Wolanskyj AP
    Eur J Haematol; 2009 Jul; 83(1):17-21. PubMed ID: 19236446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study.
    Sessarego M; Defferrari R; Dejana AM; Rebuttato AM; Fugazza G; Salvidio E; Ajmar F
    Cancer Genet Cytogenet; 1989 Nov; 43(1):57-65. PubMed ID: 2790773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-essential thrombocythemia myelofibrosis and chronic myelomonocytic leukemia can co-exist with complex cytogenetic abnormalities.
    Trakhtenbrot L; Tohami T; Schiby G; Kneller A; Rosenthal E; Rosner E; Amariglio N; Salomon O
    Leuk Res; 2010 Nov; 34(11):e308-10. PubMed ID: 20655587
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
    Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
    Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up.
    Senín A; Fernández-Rodríguez C; Bellosillo B; Camacho L; Longarón R; Angona A; Besses C; Álvarez-Larrán A
    Ann Hematol; 2018 Mar; 97(3):443-451. PubMed ID: 29181548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.
    Bernués M; González T; Corchete LA; Santos S; Durán MA; López-Andrade B; Riso LL; Martínez-Serra J; Ramos R; Iglesias J; Royo I; Rosell J
    Cancer Genet; 2022 Jun; 264-265():60-65. PubMed ID: 35397254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.
    Alvarez-Larrán A; Senín A; Fernández-Rodríguez C; Pereira A; Arellano-Rodrigo E; Gómez M; Ferrer-Marin F; Martínez-López J; Camacho L; Colomer D; Angona A; Navarro B; Cervantes F; Besses C; Bellosillo B; Hernández-Boluda JC
    Br J Haematol; 2017 Sep; 178(5):764-771. PubMed ID: 28542718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential thrombocythemia with myelofibrosis transformed into acute myeloid leukemia with der(1;15)(q10;q10): case report and literature review.
    Charafeddine KM; Mahfouz RA; Zaatari GS; Ibrahim GY; Muwakkit SA; Najm ND; Farra CG
    Cancer Genet Cytogenet; 2010 Jul; 200(1):28-33. PubMed ID: 20513531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinical characteristics of bone marrow proliferative tumor progression to acute myeloid leukemia.
    Li Y; Zhang XY; Han J; Wang L
    Cancer Biomark; 2018; 23(4):469-472. PubMed ID: 30452397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndrome with fibrosis and complex karyotype arising in a patient with essential thrombocythaemia.
    Mansor NA; Yusof N; Tang YL; Ithnin A; Azma RZ; Tumian NR; Shuib S
    Malays J Pathol; 2018 Aug; 40(2):191-197. PubMed ID: 30173238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosis.
    Li B; Xu J; Li C; Gale RP; Xu Z; Qin T; Zhang Y; Huang G; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
    Am J Hematol; 2014 Nov; 89(11):1043-6. PubMed ID: 25132428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
    Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U
    Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.